|
2024
|
Invention
|
Cannabinoid receptor type 2 (cb2) modulators and uses thereof.
Disclosed herein are compounds, c... |
|
2023
|
Invention
|
Heterocyclic inhibitors of cd73 for treatment of disease.
Provided are compounds and methods whi... |
|
|
Invention
|
Heterocyclic inhibitors of cd73 for treatment of disease.
Provided are compounds which may be us... |
|
|
Invention
|
Heterocyclic inhibitors of cd73 for treatment of disease. Provided are compounds and methods whic... |
|
|
Invention
|
Heterocyclic inhibitors of cd73 for treatment of disease. Provided are compounds which may be use... |
|
|
Invention
|
Adenosine receptor antagonists and uses thereof. 2B2B adenosine receptor activity. |
|
2022
|
Invention
|
4-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide derivatives as cannabinoid cb2 recept... |
|
|
Invention
|
Cannabinoid receptor type 2 (cb2) modulators and uses thereof. Disclosed herein are compounds, co... |
|
|
Invention
|
Adenosine receptor agonists for use in the treatment of cancer. 2B2B adenosine receptor alone or ... |
|
|
Invention
|
Methods of improving growth and function of immune cells. 22R modulator. |
|
|
Invention
|
Crystalline forms of an adenosine a2b receptor antagonist. Forms of ethyl 3-ethyl-2,6-dioxo-1-pro... |
|
2021
|
Invention
|
Cocrystals of an adenosine a2b receptor antagonist.
Cocrystals of an adenosine A2B receptor anta... |
|
|
Invention
|
Cocrystals of an adenosine a2b receptor antagonist. Cocrystals of an adenosine A2B receptor antag... |
|
|
Invention
|
Cocrystals of an adenosine a2b receptor antagonist. 2BHHH-purine-2,6-dione, methods of preparing ... |
|
|
Invention
|
Combination therapy with adenosine receptor antagonists.
Disclosed herein are compounds, composi... |
|
|
Invention
|
Combination therapy with adenosine receptor antagonists. Disclosed herein are compounds, composit... |
|
|
Invention
|
Combination therapy with adenosine receptor antagonists. 2B2B adenosine receptor in combination w... |
|
|
Invention
|
Adenosine receptor antagonists and uses thereof.
Disclosed herein are compounds, compositions, f... |
|
|
Invention
|
Monocarboxylic acid transporter 4 (mct4) modulators and uses thereof.
Disclosed herein are compo... |
|
|
Invention
|
Monocarboxylic acid transporter 4 (mct4) modulators and uses thereof. Disclosed herein are compou... |
|
|
Invention
|
Cannabinoid receptor type 2 (cb2) modulators and uses thereof. Disclosed herein are compounds of ... |
|
|
Invention
|
Adenosine receptor antagonists and uses thereof. Disclosed herein are compounds of Formula (III),... |
|
2020
|
Invention
|
Adenosine a2a receptor antagonists.
Disclosed herein are compounds, compositions, and methods fo... |
|
|
Invention
|
Adenosine a2a receptor antagonists and uses thereof. 2A2A2A2A adenosine receptor antagonists. |
|
|
Invention
|
Prostaglandin e2 receptor 4 antagonists and uses thereof.
Disclosed herein are compounds, compos... |
|
|
Invention
|
Prostaglandin e2 receptor 4 antagonists and uses thereof. Disclosed herein are compounds, composi... |
|
2019
|
Invention
|
Adenosine receptor antagonists and uses thereof. 2B2B adenosine receptor. |
|
|
Invention
|
Adenosine receptor antagonists and uses thereof. Disclosed herein are compounds, compositions, fo... |
|
2018
|
P/S
|
Pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment or... |
